医学
CD4-CD8比值
人类免疫缺陷病毒(HIV)
抗逆转录病毒疗法
CD8型
不利影响
重症监护医学
免疫学
免疫系统
内科学
病毒载量
淋巴细胞亚群
作者
Raquel Ron,Elena Moreno,Javier Martínez‐Sanz,Fátima Brañas,Talía Sainz,Santiago Moreno,Sergio Serrano Villar
摘要
In the last decade, studies in persons with HIV (PWH) on antiretroviral therapy (ART) have shed light on the significance of persistently high CD8 counts and low CD4/CD8 ratios. A low CD4/CD8 ratio reflects increased immune activation and is associated with an increased risk of severe non-AIDS events. As a result, many clinicians now believe that the CD4/CD8 ratio can help in HIV monitoring, and many researchers now report it as an efficacy marker in interventional studies. However, the topic is more complex. Recent studies have not yielded unanimous conclusions on the ability of the CD4/CD8 ratio to predict adverse outcomes, and only some clinical guidelines recommend monitoring it. Knowledge gaps remain on the best cutoff points, associated clinical events, effects of treatments, and how the CD4/CD8 ratio could improve decision making in the clinic. Here, we critically review the literature, identify knowledge gaps, and discuss the role of the CD4/CD8 ratio as a marker for HIV monitoring.
科研通智能强力驱动
Strongly Powered by AbleSci AI